 |
|
|
|
 |
|
|
Fipexide
|
|
Fipexide
|
| Systematic (IUPAC) name |
1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-
2-(4-chlorophenoxy)ethanone |
| Identifiers |
| CAS number |
34161-24-5 |
| ATC code |
N06BX05 |
| PubChem |
3351 |
| Chemical data |
| Formula |
C20H21ClN2O4 |
| Mol. mass |
388.845 g/mol |
| Pharmacokinetic data |
| Bioavailability |
? |
| Metabolism |
? |
| Half life |
? |
| Excretion |
? |
| Therapeutic considerations |
| Pregnancy cat. |
?
|
| Legal status |
|
| Routes |
? |
Fipexide is a piperazine derivative drug invented in Italy in 1983.[1]
It was used as a nootropic drug in France and Italy, mainly for the treatment of senile dementia,[2] but is no longer in common use due to the occurrence of rare adverse drug reactions including fever[3] and hepatitis. Fipexide is similar in action to other nootropic drugs such as piracetam and is structurally similar to another more well-known nootropic, centrophenoxine.
References
- ^ Missale C, Pasinetti G, Govoni S, Spano PF, Trabucchi M. Fipexide: a new drug for the regulation of dopaminergic system at the macromolecular level. Bollettino Chimico Farmaceutico. 1983 Feb;122(2):79-85.
- ^ Bompani R, Scali G. Fipexide, an effective cognition activator in the elderly: a placebo-controlled, double-blind clinical trial. Current Medical Research and Opinion. 1986;10(2):99-106.
- ^ Guy C, Blay N, Rousset H, Fardeau V, Ollagnier M. Fever caused by fipexide. Evaluation of the national pharmacovigilance survey. Therapie. 1990 Sep-Oct;45(5):429-31.
|
| |
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Fipexide". A list of authors is available in Wikipedia.
|
|
|
|
|
|
Top